In another post Denninger comments on the EVMS Critical Care COVID-19 Management Protocol.
Our treatment protocol targeting these key pathologies has achieved near uniform success, if
begun within 6 hours of a COVID19 patient presenting with shortness of breath or needing ≥
4L/min of oxygen.
It's based on "...employ[ing] anti-inflammatory and anticoagulant treatments, including corticosteroid therapy early in the course of a patient’s hospitalization." It sounds reasonable to this layman. Have the professionals here heard of it? @jfsully any thoughts?